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In Brief Tortosa et al. show that MAP6 redistributes from Golgi and secretory vesicles to axonal microtubules during neuronal polarization. Palmitoylation cycles control MAP6 membranemicrotubule shuttling. The authors also demonstrate the importance of MAP6 for microtubule stabilization, organelle trafficking, and axon maturation.
INTRODUCTION
The majority of neurons display a polarized morphology with two structurally and functionally well-defined compartments. Several short and branched dendrites receive information, while a thin and long axon is responsible for transmitting a message to other neurons. During early stages of neuronal development, axon formation is a crucial step in breaking symmetry and establishing neuronal polarization. Microtubules are a major determinant in the establishment of the axon and, because of their inherent polarity, are well suited to provide the structural basis for neuronal polarization (Kapitein and Hoogenraad, 2015) . Several studies have identified signaling factors that regulate this process, many of which converge onto the cytoskeleton (Arimura and Kaibuchi, 2007) . However, the molecular processes that control microtubule organization and remodeling during the initial stages of neuronal polarization remain elusive.
Axon initiation and outgrowth are characterized by the formation of stable and uniform parallel microtubule bundles with their plusends pointing outward toward the growth cone (Baas and Lin, 2011) . These bundled microtubules may provide the mechanical forces that drive axon elongation in neurons (van Beuningen and Hoogenraad, 2016) . Interestingly, axonal microtubules are stabilized before axon elongation and remain stable during the subsequent stages of neuronal development (Baas et al., 1991; Kollins et al., 2009; Witte et al., 2008; Yau et al., 2016) . It has been shown that local stabilization of microtubules using the microtubule-stabilizing drug paclitaxel is sufficient to break symmetry and specify axon formation in unpolarized neurons (Witte et al., 2008) . Moreover, paclitaxel-induced microtubule stabilization induces the formation of multiple axons out of differentiated dendrites in fully mature neurons (Gomis-R€ uth et al., 2008) . Thus, although it is clear that stabilizing microtubules is a key process during axon formation, little is known about the mechanisms that stabilize axonal microtubules throughout development.
An important challenge is to identify factors that control neuronal polarization by setting up axon-specific microtubule stabilization. A large variety of microtubule-associated proteins (MAPs) have been characterized and they are main candidates to mediate microtubule stabilization. MAPs are found along neuronal microtubules arrays and regulate microtubule polymerization, bundling, and/or stabilization. Interestingly, many of these proteins present specific localizations in the neuron during the different stages of neuronal development (Conde and Cá -ceres, 2009) . Although the precise localization is likely crucial for their proper function, how MAPs are specifically localized in different compartments still remains elusive. A combination of several mechanisms, including differential protein stability and turnover, specific localization of mRNAs, or the suppression of axon-dendrite sorting have been proposed to play a role in the (legend continued on next page) polarization of MAPs, like MAP2 and Tau (Garner et al., 1988; Hirokawa et al., 1996; Kanai and Hirokawa, 1995; Li et al., 2011; Okabe and Hirokawa, 1989) .
MAP6, also known as STOP (stable tubule only peptides), is particularly interesting because it is enriched in axons and has powerful microtubule stabilizing activity. In particular, MAP6 is responsible for the resistance of neuronal microtubules to cold and the microtubule-destabilizing drug nocodazole (Bosc et al., 1996; Guillaud et al., 1998) . Interestingly, MAP6-depleted mice show schizophrenic-like behaviors, which can be suppressed by the microtubule-stabilizing drug epothilone D (Andrieux et al., 2002; Fournet et al., 2012) . Therefore, it is of interest to understand how MAP6 is targeted to axonal microtubules and explore its potential role as microtubule stabilizer in neuronal development.
In this study, we demonstrate that MAP6 is present at the Golgi complex and in secretory vesicles in unpolarized cells and redistributed to newly forming axons, where it binds and stabilizes axonal microtubules. A palmitoylation cycle controls MAP6 membrane-microtubule shuttling and is required for its polarized distribution in axons. Our results reveal a regulatory role for MAP6 in stabilizing axonal microtubules and coordinating KIF5-mediated axonal transport during neuronal development and provide evidences for a new mechanism of axonal targeting.
RESULTS

MAP6 Forms a Stable Compartment in the Proximal Axon
In order to identify MAPs responsible for stabilizing axonal microtubules during neuronal development, we first analyzed the polarized distribution of several MAPs in hippocampal neurons by measuring the dendrite-to-axon ratio and calculated the polarity index (PI) . Interestingly, MAPs like MAP1A and MAP1B switched from axonal to a more dendritic polarized distribution during neuronal maturation. Others like MAP6 and Tau were highly enriched in the axonal compartment. In agreement with published data (Schwenk et al., 2014) , some dendritic staining for MAP6 was observed, becoming more prominent in more mature neurons ( Figures 1A, 1B , S1A, and S1B). Interestingly, MAP6 showed a preferential localization in the more proximal part of the axon, while Tau was enriched at the distal region ( Figures 1C, 1D , and S1C). Consistently, MAP6 and Tau proteins relocated to newly formed axons after paclitaxel treatments and separated into distinct axonal domains ( Figures  1E and 1F) . To determine the dynamics of both proteins in axons, we performed fluorescence recovery after photobleaching (FRAP) analysis of GFP-tagged Tau and both neuronal MAP6 isoforms, MAP6-E and MAP6-N. The fluorescence recovery of both MAP6 isoforms was remarkably slow and incomplete when compared to Tau ( Figures 1G and 1H ), indicating that a large fraction of MAP6 molecules is highly immobile and that MAP6 forms a relatively stable compartment in the proximal axon. In agreement with these data, immunofluorescence of embryonic brain sections showed that MAP6 was highly enriched in axons from the hippocampus and corpus callosum, overlapping with the axonal marker high molecular weight neurofilament subunit (NF-H) ( Figure 1I ). MAP6 features interesting microtubule stabilizing properties and, while Tau has been studied extensively before (Dawson et al., 2001; Takei et al., 2000) , MAP6 function in neurons is not well understood (Bosc et al., 1996; Guillaud et al., 1998) . Therefore, we focused on MAP6 and its role as axonal microtubule stabilizer during neuronal polarization.
MAP6 Stabilizes Microtubules in the Axonal Compartment
Previous works show that MAP6 localizes along neuronal microtubule arrays in axons (Guillaud et al., 1998; Slaughter and Black, 2003) . We further examined the interaction between MAP6 and microtubules, and its relevance for axonal microtubule organization. MAP6-GFP expression in COS-7 cells labeled a subset of stable (detyrosinated and acetylated) microtubules ( Figures  2A-2C ). Similar results were obtained in neurons where both endogenous MAP6 and overexpressed MAP6-GFP coincided with stable microtubule bundles ( Figure 2D ). Neurons transfected with MAP6 shRNAs and stained for EB1 as a marker for dynamic microtubules showed an increased number of the characteristic comets marking microtubules plus-end in soma, whereas no differences were detected in dendrites (Figures 2E, 2F, S2A, and S2B) . Further, when we visualized microtubule growth by using the plus-end marker GFP-MT+TIP in axons, we observed a similar increase in dynamic microtubules upon MAP6 depletion in axons ( Figure 2G ). We did not detect any differences in microtubule orientation, growth rate, time, or run length between MAP6 knockdown and control neurons ( Figures  S2C and S2D) . Consistently, the staining for detyrosinated tubulin was reduced, whereas levels of tyrosinated tubulin were unaltered in neurons depleted of MAP6 ( Figures 2H, 2I , and S2E). Additionally, FRAP experiments examining the recovery of b-tubulin-GFP confirmed that axonal microtubules were less stable in MAP6-depleted neurons ( Figures 2J and 2K ). Overall, our data suggest that MAP6 stabilizes axonal microtubules.
MAP6 Promotes KIF5-Mediated Organelle Trafficking in Axons
Previous studies showed that kinesin-1/KIF5-mediated transport has high affinity for stabilized and/or modified microtubules Red and green arrowheads point to axons and dendrites, respectively. Graphs represent mean ± SEM in (B) and (H) . Scale bar represents 100 mm in (I), 40 mm in zooms in (I), 20 mm in (A), (C), and (E), 10 mm in zooms in (C), and 5 mm in (G). See also Figure S1 . (Cai et al., 2009; Nakata and Hirokawa, 2003) . Hence, we tested how MAP6-stabilized microtubules influence KIF5-based mitochondrial trafficking by using live-cell imaging of Mito-dsRed. In the absence of MAP6, mitochondrial motility in axons was reduced by $25% (Figures 3A) . While the velocity did not change, the duration and length of the mitochondrial runs decreased ( Figure S3A ). MAP6 depletion affected both the anterograde and retrograde transport parameters ( Figure S3B ), suggesting that MAP6 plays a role in coordinating bidirectional axonal transport. Interestingly, co-expression of KIF5B-GFP together with MAP6-mCherry in MRC-5 cell line suggests that KIF5B preferentially moves on MAP6-positive microtubules ( Figures S3C-S3E) . Additionally, the number of runs for KIF5B-GFP slightly increased in MAP6-labeled microtubules when compared to control (Figures S3F and S3G) . Consistently, MAP6 knockdown decreased the number of runs for KIF5B-GFP in neurons ( Figure 3B ). We did not detect any differences in KIF5B-GFP velocities in both MAP6 knockdown and overexpression ( Figures S3H and S3I ). Finally, using the inducible cargo trafficking assay, we also found strongly reduced KIF5-driven cargo runs in axons of MAP6 knockdown neurons ( Figure S3J ). Together, the data suggest that MAP6 promotes KIF5-mediated axonal cargo transport.
MAP6 Controls Axon Maturation In Vitro and In Situ
To further study the function of MAP6 in neurons, we next determined whether MAP6 plays a role in axon growth. We performed shRNA knockdowns of several MAPs in polarized hippocampal neurons and used paclitaxel to induce the formation of new axons (Gomis-R€ uth et al., 2008; Witte et al., 2008) . Most cultured hippocampal neurons at 6 days in vitro (DIV6) presented one axon, which was identified by the presence of voltage-gated sodium channels (Na v ), an axon initial segment (AIS) marker. Treatments with low concentrations of paclitaxel strongly increased the number of neurons with multiple axons. In contrast to MAP2-depleted cells, paclitaxel-induced axonal processes did not emerge in neurons lacking Tau or MAP6, suggesting a role for these two MAPs in axon formation ( Figures S4A-S4C ). To further determine whether MAP6 is involved in axon growth during the initial stages of neuronal polarization, we electroporated cortical neurons with several MAP6 shRNAs and stained for various axonal makers at DIV3-DIV4. While most MAP6 knockdown neurons were positive for the early axonal markers Tau and TRIM46 ( Figures 3C and 3E ), the AIS (as visualized by Na v channels) was largely absent (Figures 3D and 3F ). The AIS phenotype was rescued by overexpressing MAP6-GFP in MAP6-depleted neurons ( Figure 3F ). Consistent with an axonal defect, we observed a marked reduction in the total axonal length in MAP6 knockdown neurons ( Figure 3G ). Finally, we examined whether MAP6 plays a role during neuron polarization in situ. Mouse brains were electroporated in utero at E14.5 with control and MAP6 shRNAs, together with GFP to visualize neuronal morphology. Control neurons efficiently migrated to the upper layers of the cortical plate and developed a typical bipolar morphology with a leading process and a trailing edge. In contrast, MAP6-depleted neurons failed to migrate properly and accumulated in the ventricular and subventricular zones ( Figures  3H and 3I ). Interestingly, upon MAP6 depletion most of the neurons seemed to be properly orientated. However, fewer neurons displayed the typical bipolar morphology; many neurons seemed to display shorter leading processes and often lacked the trailing processes ( Figures 3J and 3K ). Altogether, these data demonstrate the role of MAP6 in axon maturation and neuronal migration. However, since both neuronal migration and axon maturation are strongly dependent on each other, we cannot rule out that the observed axonal phenotype in situ is caused by abnormal cell migration.
MAP6 Is Present at the Golgi Apparatus and Secretory Vesicles
In addition to its axonal localization, MAP6 has also been reported to associate with the Golgi apparatus and vesicular structures (Gory-Fauré et al., 2006 . Indeed, at DIV4, we detected MAP6 in axons, at the Golgi complex in the cell body, as well as in vesicles that accumulate at the tip of some neurites ( Figure 4A ). We observed similar results upon expression of MAP6-GFP in cultured neurons ( Figure 4B ). Subsequently, we investigated the identity of the MAP6-positive vesicles by staining for various vesicular markers, including secretory vesicles (Rab6), lysosomes (LAMP1), and synaptic precursor vesicles (Rab3). In unpolarized neurons, MAP6 strongly co-localized with Rab6-positive secretory vesicles and was excluded from ). These data show that MAP6 is present in the axon and at the Golgi complex and secretory vesicles in developing neurons.
MAP6 Becomes Highly Enriched in Axons during Neuronal Polarization
Given the differential MAP6 localizations in unpolarized and polarized neurons, we decided to analyze in more detail the expression and distribution of MAP6 during early stages of neuronal development. Western blot analysis of embryonic and postnatal brains and hippocampal neuron culture extracts showed that the MAP6 isoform MAP6-E was expressed in the brain at early embryonic stages and, in dissociated neurons, before neuronal polarization (DIV1), with increased expression as the development progressed. The other neuronal MAP6 isoform, MAP6-N, was expressed only after birth and in more mature neurons in culture ( Figures 5A and 5B). By co-staining unpolarized (stage 2) and polarized (stage 3) neurons with markers for the axon (Tau), AIS (Na v channels), and Golgi apparatus (GM130), we studied MAP6 distribution during neuronal polarization. In unpolarized cells, MAP6 was present at the Golgi complex ( Figures 5C and 5D ). Directly following the polarization, MAP6 became enriched in Tau-positive and AIS-negative axons (Figures 5E, 5F, and S5J). These results show that MAP6 is enriched in developing axons before AIS formation. Consistently with previous observations (Schwenk et al., 2014) 
N-Terminal Domain Palmitoylation Controls MAP6 Distribution in Neurons
Protein palmitoylation is a reversible lipid modification that facilitates protein insertion into intracellular and plasma membranes and allows proteins to rapidly shuttle between intracellular compartments (Fukata and Fukata, 2010) . Previous studies have shown that palmitoylation mediates the binding of MAP6 to Golgi membranes (Gory-Fauré et al., 2006 . To determine whether palmitoylation also controls the vesicular localization of MAP6 in neurons, we mutated three cysteines (Cys 5, 10, and 11) in the N-terminal region of MAP6 (MAP6-GGG) (GoryFauré et al., 2014) . As expected, MAP6-GGG was still able to bind microtubules but did not localize either to Golgi apparatus or to secretory vesicles (Figures 6A and 6B) . Interestingly, the palmitoylation-defective MAP6 mutant mislocalized to dendrites and lost the axonal enrichment observed in control . To further investigate whether palmitoylation is required for MAP6 polarization, we generated GFP-tagged N-terminal, microtubule-binding, and C-terminal domains of MAP6 (Figures 6A and S5L) . In contrast to the other constructs, the N-terminal domain localized to Golgi membranes and was enriched in the axon. Furthermore, when palmitoylation sites were mutated (Nterm-GGG), the N-terminal domain localized to dendrites and lost its axonal polarization ( Figures 6C-6F ).
Despite the axonal enrichment of the N-terminal domain, the number of NPY-GFP-labeled secretory vesicles did not increase in the axon and revealed a nonpolarized distribution in DIV4 neurons (Figures 6G and 6H) . This suggests that axonal MAP6 targeting is not due to a selective distribution of secretory vesicles in developing neurons. At the same time, neither MAP6 knockdown nor overexpression affected the secretory vesicle distribution ( Figure 6H ). Interestingly, while the N-terminal domain revealed a vesicular localization in the soma and proximal region of the axon, it had a diffuse, cytosolic distribution in the more distal regions of the axon. Conversely, NPY-positive vesicles were observed along the length of the axon, including distal regions ( Figure 6I ). These results indicate that palmitoylation at the N-terminal region is required to bind MAP6 to secretory vesicles and to target MAP6 to axons. Once MAP6 reaches the axon, it de-attaches from the vesicles and becomes enriched in the axon. Based on these results, we proposed that palmitoylation cycles control MAP6 localization and, consequently, its axonal polarization.
Palmitoylation Cycles Regulate MAP6 Localization and Polarization Dynamic palmitoylation is controlled by the DHHC family of palmitoyl transferases and depalmitoylating enzymes (Fukata and Fukata, 2010) . COS-7 cells transfected with MAP6-GFP and treated with Palmostatin B (PalB), an inhibitor of depalmitoylating enzymes, showed no changes in the number of MAP6-positive vesicles. However, a marked decrease in the number of microtubules labeled with MAP6-GFP was observed ( Figures 7A and 7B ). Likewise, treatments with 2-Bromopalmitate (2-BP), a general protein palmitoylation inhibitor, reduced the number of vesicles positive for MAP6 and strongly increased the microtubule localization as shown both in fixed and live cells (Figures 7A-7E ; Movie S3). The number of Rab6-labeled secretory vesicles was not affected ( Figure 7F ), suggesting that MAP6 membrane-microtubule shuttling is regulated by protein palmitoylation. We next determined whether 2-BP and PalB treatments also affect MAP6 polarized sorting in cultured neurons. Inhibition of both palmitoylation and depalmitoylation strongly reduced selective MAP6 enrichment in axons, causing a reduction in the PI by $60% for PalB and $35% for 2-BP ( Figures 7G and 7H ). To better understand how these drug treatments affect MAP6 localization to vesicles, we transfected neurons with the N-terminal domain of MAP6 fused to GFP and treated them with PalB and 2-BP. Treatments with PalB increased the number of MAP6-positive vesicles in the distal part of the axon, whereas 2-BP caused loss of N-terminal domain's vesicular localization ( Figures 7I-7K ). The number of NPY-positive secretory vesicles was unchanged ( Figure S5M ). Interestingly, disrupting intracellular calcium concentration with BAPTA or ionomycin also affected the localization of MAP6 to vesicles. BAPTA mimicked PalB treatment ( Figures 7I-7K and S5M) , suggesting that palmitoylation cycles may be regulated by axonal calcium flux.
Together, these results demonstrate that palmitoylation cycles control not only MAP6 shuttling between secretory vesicles and microtubules, but also its axonal polarization.
ABHD17B Depalmitoylating Enzyme Controls MAP6 Palmitoylation and Mediates in Its Localization and Polarization
Depalmitoylating enzymes catalyze palmitate removal from cysteine residues, regulating protein localization and function Fukata and Fukata, 2010) . Recently, a family of depalmitoylating enzymes, a/b-Hydrolase domaincontaining protein 17 members (ABHD17A, 17B, and 17C), has been found to regulate PSD95 depalmitoylation (Yokoi et al., 2016) . We next tested which depalmitoylating enzymes show specificity for MAP6. COS-7 cells co-transfected with MAP6-GFP and depalmitoylating enzymes ABHD12 and 13, APT-1, and APT-2 showed no changes in the number of MAP6-positive vesicles and MAP6-labeled microtubules. However, coexpression of ABHD17 family members markedly reduced the number of vesicles positive for MAP6 and strongly increased the microtubule localization ( Figure 8A ). To determine whether these depalmitoylating enzymes also affect MAP6 localization in neurons, we co-expressed them together with the N-terminal domain of MAP6 fused to GFP. In agreement with COS-7 data, expression of depalmitoylating enzymes ABHD17A, B, or C all reduced the number of MAP6-positive vesicles ( Figure 8B) . Interestingly, overexpression of ABHD17B also affected N-terminal domain polarization in neurons ( Figure 8C ). The catalytically inactive mutant ABHD17B D235A has been suggested to act as a substrate-trapping mutant, inhibiting the action of endogenous depalmitoylating enzymes (Yokoi et al., 2016) . Although we did not observe changes in the PI, overexpression of the mutant form markedly increased the number of MAP6-positive vesicles in the distal part of the axon (Figures 8D and S5N) . Importantly, all changes observed in MAP6 localization and polarization correlated with changes in its palmitoylation levels, detected by Acyl-RAC assays. In particular, overexpression of ABHD17B decreased the palmitoylation levels of endogenous MAP6 in neurons ( Figures 8E  and 8F ). Finally, ABHD17B also affected endogenous MAP6 polarization in cultured neurons; ABHD17B strongly increased MAP6 enrichment in dendrites, causing a reduction in its PI ( Figures 7G and 7H ). In conclusion, our data strongly indicate that MAP6 depalmitoylation, mediated by the ABHD17 family members, regulates the localization of MAP6 between secretory vesicles and microtubules and controls its polarized distribution in axons.
DISCUSSION
Neuronal polarization is a highly coordinated and rigorously regulated process that requires a compartment-specific distribution of axonal and dendritic components and a complete reorganization of the microtubule cytoskeleton. Among other events, stabilization of axonal microtubules is an important step in this process. In this study, we describe the palmitoylation/depalmitoylation cycle as an important molecular process to selectively target MAP6 into axons. We demonstrate that palmitoylated MAP6 localizes to Golgi and secretory vesicles in unpolarized cells. During axon formation, MAP6 is depalmitoylated and deattached from vesicles, becoming enriched in the newly formed axon. Our data suggest that the presence of MAP6 defines a specific axonal compartment, where it binds and stabilizes microtubules, regulates efficient organelle trafficking, and controls axon maturation in vitro and in situ.
Microtubule Stabilization and Axon Formation
Microtubules have emerged as crucial players in neuronal development and function (Conde and Cá ceres, 2009; Hoogenraad and Bradke, 2009) . MAPs have been shown to be important in neuronal polarization and are the main candidates to mediate microtubule stabilization (Poulain and Sobel, 2010) . Particularly, it has been reported that MAP6/STOP is responsible for microtubule stabilization under various conditions such as exposure to cold or depolymerizing drugs (Andrieux et al., 2002; Bosc et al., 1996; Guillaud et al., 1998) . Note worthily, MAP6-depleted mice are viable but they show axonal defects and display various behavioral phenotypes (Andrieux et al., 2002; Deloulme et al., 2015; Fournet et al., 2012) . Interestingly, treatments with microtubule-stabilizing drugs diminished these deficits (Daoust et al., 2014; Fournet et al., 2012) , indicating that MAP6 is a major candidate for mediating microtubule stabilization in vivo. However, little is known about the precise microtubule-stabilizing function of MAP6 in neurons. Here, we demonstrate that depletion of MAP6 induces an increase in dynamic microtubules, accompanied by a decrease of detyrosinated tubulin levels and a higher fluorescence recovery of tubulin after photobleaching in axons, altogether pointing to MAP6 as microtubule stabilizer in neurons. Previous work showed that MAP6 associates preferentially with microtubules containing low levels of tyrosinated tubulin and this interaction is independent of microtubule polyglutamylation (Bonnet et al., 2002; Slaughter and Black, 2003) . Consistently, we found that MAP6 binds a specific subset of stable (acetylated and detyrosinated) microtubules. It is tempting to speculate that MAP6 binding induces axonal microtubule stabilization, although we cannot rule out the possibility that MAP6 recognizes stable microtubules and acts to further increase their stability.
While we provide evidence for MAP6-dependent mechanism of microtubule stabilization, it is probable that parallel mechanisms exist in order to organize and stabilize microtubules during axon formation (DiTella et al., 1996; Teng et al., 2001 ). Other MAPs, such as CAMSAP2 and TRIM46, have been recently shown to mediate microtubule organization by stabilizing non-centrosomal microtubules and forming uniform microtubule arrays before the formation of Tau-positive axons Yau et al., 2014) . It is plausible that MAP6 may further promote microtubule stabilization of bundles formed by CAMSAP2 and TRIM46. In the more distal part of the axon, microtubules may be stabilized by other MAPs, such as MAP1B or Tau. Furthermore, we found that MAP6 promotes KIF5B-dependent movement and drives efficient mitochondria transport into the axon. As it has been shown for other MAPs, MAP6 could act as a cofactor required for KIF5B-dependent transport or recruit motor proteins to the microtubule (Barlan et al., 2013; Sung et al., 2008) . Another possibility is that the binding of MAP6 to axonal microtubules induces conformational changes that promote KIF5B-driven movement into the axon (Tokuraku et al., 2007) . Regardless of the precise regulatory mechanism, we show that MAP6 stimulates cargo transport into the developing axon. Interestingly, other MAPs like MAP2 have recently been shown to control cargo trafficking by inhibiting KIF5B motor activity (Gumy et al., 2017) .
Palmitoylation Is a Mechanism to Target Proteins to the Axonal Compartment
Two different mechanisms have been proposed to mediate compartment-specific localization of proteins in neurons: selective sorting and selective retention. Whereas some of the axonal or dendritic components are specifically sorted into their final destination, others are transported to both axons and dendrites and are selectively retained in the correct compartment. Palmitoylation has been shown to mediate the localization of neuronal proteins, such as PSD-95, GAP-43, or GAD-65. Interestingly, cycles of palmitoylation and depalmitoylation not only control the localization, but also the activity of palmitoylated proteins, (E) GFP mean intensity in axons and dendrites of 2DIV hippocampal neurons expressing MAP6-FL, MAP6-GGG, and the different MAP6 domains (n = 15-33 neurons; Kruskal-Wallis test followed by a Dunn's multiple comparison test). regulating processes like the establishment of axon-dendrite polarity or axon growth, guidance, and maintenance (Fukata and Fukata, 2010; Holland and Thomas, 2017) . Taken together, results we present here lead us to the conclusion that palmitoylation/depalmitoylation cycles act as a novel mechanism to polarize MAPs neurons.
Model for Controlling MAP6 Membrane-Microtubule Shuttling in Axons
Palmitoylation at the N-terminal region of MAP6 targets the protein to Golgi compartments (Gory-Fauré et al., 2006 . However, the relevance of this lipid modification remained unknown. The absence of the N-terminal domain in MAP6 isoforms present in fibroblasts, astrocytes, and oligodendrocytes (A-, O-, and F-MAP6) suggests that MAP6 palmitoylation may be a unique neuronal feature Galiano et al., 2004) . In this study, we show that protein palmitoylation is required for anchoring MAP6 to vesicles and that local depalmitoylation and microtubule binding causes the specific retention of MAP6 in the axon. Interestingly, the same family of a/b Hydrolase domain-containing protein 17 depalmitoylating enzymes involved in PSD-95 and N-Ras depalmitoylation (Lin and Conibear, 2015; Yokoi et al., 2016) control MAP6 palmitoylation, regulating its localization in membranes and microtubules, and its enrichment in axons. Furthermore, previous works have already proposed calcium as a regulatory mechanism of palmitoylation cycles Fivaz and Meyer, 2005; Yeh et al., 1999; Zhang et al., 2014) . Here, we show that calcium regulates the localization of MAP6 at vesicles, suggesting that MAP6 de-/palmitoylation may be regulated by calcium flux in axons. However, additional studies are needed to elucidate the processes controlling axonal MAP6 depalmitoylation. We propose a model in which palmitoylated-MAP6 bound to secretory vesicles establishes the initial transport from Golgi to dendrites and axons. Once deplamitoylated MAP6 deattaches from the vesicles, it accumulates in the axon. Regardless of the precise regulatory mechanism, after depalmitoylation, the vesicle-unbound state of MAP6 recognizes a specific subset of microtubules to promote axonal microtubule stabilization.
Microtubule stabilization and/or axon-enriched MAP6 may promote delivery of cargo vesicles to the axon or even certain polarity factors that directly contribute to axonal maturation. Our current findings also provide new molecular targets to investigate defects in the polarized sorting machinery in neurodevelopmental disease models.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Hippocampal neurons were transfected using Lipofectamine 2000 (Invitrogen). Briefly, DNA (1.8 mg/well, of a 12 wells plate) was mixed with 3.3 mL of Lipofectamine 2000 in 200 mL NB, incubated for 30 min, and then added to the neurons in NB at 37 C in 5% CO 2 for 45 min. Next, neurons were washed with NB and transferred to their original medium at 37 C in 5% CO 2 for 24h (for overexpression) or 72h (for shRNA expression).
Primary cortical neurons (1.3 3 10 6 cells) were nucleofected with 3 mg of DNA using the Amaxa Rat Neuron Nucleofector kit (Lonza) according to the manufacturer's instructions. Cells were maintained for 3 days (knockdown experiments) or 1 day (other experiments) at 37 C in 5% CO 2 before imaging or fixation. For immunocytochemistry, cells were fixed for 10 min with paraformaldehyde (4%) or for 5 min with methanol (100%) containing 1mM EGTA at À20 C followed by 5 min paraformaldehyde (4%). Cells with low expression levels of the different constructs were used in all the analysis.
Heterologous cell culture and transfection African Green Monkey SV40-transformed kidney fibroblast (COS-7) and Human Fetal Lung Fibroblast Cells (MRC-5) cells were from ATCC and cultured in DMEM/Ham's F10 (50%/50%) supplemented with 10% FCS and 1% penicillin/streptomycin at 37 C and 5% CO 2 . Cell lines were not authenticated by authors after purchase. Cells were plated in 18mm glass coverslips and transfected with Fugene6 (Promega) according to manufacturer's protocol. Cells with low expression levels of the different constructs were used in all the studies.
In utero electroporation
In utero electroporation was performed as described previously . Briefly, pregnant female C57BL/6 mice (Jackson Laboratories) were anaesthetized with Isoflurane (induction: 3%-4%, surgery, 1.5%-2%) and injected with 0.05mg/kg buprenorfinhydrochloride in saline at E14.5. The abdominal cavity was opened and uterine horns were exposed under sterile surgical conditions. 1.7 mL DNA mixture containing 0.6 mg/mL pSuper vector or MAP6 shRNAs, and 0.4 mg/mL GFP vector dissolved in MilliQ water with 0.05% Fast Green (Sigma) was injected in the lateral ventricles of the embryos (both males and females) using glass micro-pipettes (Harvard Apparatus) and a PLI-100 Picoinjector (Harvard Apparatus). Brains (motor cortex) were electroporated with gold plated tweezer-electrodes (Fischer Scientific) using an ECM 830 Electro-Square-Porator (Harvard Apparatus) set to three unipolar pulses at 30V (100ms interval and pulse length). Embryos were placed back into the abdomen, and abdominal muscles and skin were sutured separately. Mother mice were awakened by releasing them from Isoflurane. Whole heads of embryos were collected at E17.5 and processed for immunohistochemistry. The percentage of neuronal migration was quantified as described previously (Hand et al., 2005) .
METHOD DETAILS
DNA and shRNA Constructs MAP6 clones were kindly provided by both Dr. Annie Andrieux (Grenoble Institut des Neurosciences) and Prof. Dr. Dieter Edbauer (DZNE-M€ unchen). All MAP6 expression constructs were generated by a PCR-based strategy and placed in GW1 vector . In palmitoylation-defective MAP6 mutant (MAP6-GGG and N-terminal-GGG) cysteins C5, C10 and C11 were mutated to glycine residues by a PCR-based strategy. C-terminal GFP-tagged MAP6-E isoform was used in most of overexpression experiments, excluding Figures 6B and 6D . In young neurons, although both C-terminal and N-terminal GFP-tagged version of MAP6-E present a polarized distribution, only MAP6-GFP distribution matches nicely with the endogenous MAP6 in proximal axons, where both, endogenous and overexpressed protein, bind microtubules. GFP-MAP6 full length doesn't seem to be so efficient in binding microtubules, therefore it does not accumulate in proximal axons and becomes enriched in more distal regions.
Plasmids for depalmitoylating enzymes ABHD12, 13, 17A/B/C, APT1 and 2, and the ABHD17B mutant construct ABHD17B D235A have been previously described (Yokoi et al., 2016) . The following mammalian expression plasmids have been previously described: pSuper vector (Brummelkamp et al., 2002) , GFP-Tau 4R (Lu and Kosik, 2001 ), GFP-MACF43 (Honnappa et al., 2009 ) which we named GFP-MT+TIP since it is used as a general marker to analyze the dynamics of microtubule growing plus-ends, NPY-GFP , mCitrine-Nras (Rocks et al., 2005) , NPY-RFP (Grigoriev et al., 2007) , tagRFP-Rab6 (Schlager et al., 2014 ), mito-dsRed (van Spronsen et al., 2013 , pGW1-GFP, KIF5B(1-807)-GFP and constructs used for the inducible cargo trafficking assay including KIF5B(1-807)-HA-FRB and PEX3-RFP-FKBP . GW2-BFP was created by inserting BFP into HindIII/ AscI sites of a GW2 backbone. b-tubulin-GFP was a kind gift from Dr. P. Sch€ altze and Dr. K. Jiang. The following shRNAs were used in this study: rat/mouse MAP6-shRNA#1 (5 0 -ggtgcagatcagcgtgaca À3 0 ) and rat MAP6-shRNA#2 (5 0 -gatggtgactcgcacc gaa-3 0 ) (Schwenk et al., 2014) , mouse MAP6 shRNA#2 (5 0 -gatggtgactcgcacggaa À3 0 ) and rat MAP6-shRNA#3 (5 0 -ccagtaagcccac cacagcggacaa À3 0 ). MAP1A shRNA #1 (5 0 -gctctttcgtcgaagataa À3 0 ) and MAP1A shRNA #2 (Szebenyi et al., 2005) , MAP1B shRNA (adapted from (Tortosa et al., 2013) ; 5 0 -gcccaagaaggaagtggct-3 0 ), MAP2-shRNA and Tau-shRNA (Leugers and Lee, 2010) .
Antibodies and reagents
The following antibodies were used in this study: rabbit anti-MAP6 (kind gift from Dr. Annie Andrieux), goat anti-MAP1A (Santa Cruz Biotechnology, sc8969, RRID: AB_649150), goat anti-MAP1B (Santa Cruz Biotechnology, sc8970, RRID: AB_649156), chicken Devices) software. Two-color laser total-internal-reflection fluorescence (TIRF) microscopy with a 100x objective (Apo TIRF, NA1/4 1.49; Nikon), a Photometrics Evolve Delta 512 EMCCD camera (Roper Scientific) and an incubation chamber (Tokai Hit) was performed for KIF5B-GFP imaging experiments. Coverslips were mounted in metal rings and imaged using an incubation chamber that maintains temperature and CO 2 optimal for the cells (37 C and 5% CO 2 ). Neuron live imaging was performed in full conditioned medium and fresh medium was added to COS-7 before imaging.
Time-lapse live-cell imaging of GFP-MACF43 and mito-dsRed was performed with time acquisition intervals of 1sec for 2-3min. For MAP6-GFP imaged together with NPY-GFP/-RFP or RFP-Rab6, the time acquisition intervals were 100 ms for 20 s to 3 min. Imaging GFP-tagged MAP6 N-terminal fragment a time interval acquisition of 200 ms for 40 s was used. For KIF5B-GFP experiments, the time interval was 100 ms for 10-20 s. For MAP6-GFP imaging, the time acquisition interval was 1min for 3h, in COS-7 cells, and 10 min for overnight imaging in neurons.
Teem Photonics 355 nm Q-switched pulsed laser was used to perform laser-induced severing and study microtubule orientation in axons as describe previously (Yau et al., 2016) . No signs of toxicity or blebbing of cells was observed during laser-induced severing.
Fluorescence recovery after photobleaching
The experiments were performed using the ILas2 system (Roper Scientific). A region at the proximal axon was bleached with high laser power and fluorescence recovery was observed for a period of 10min. For FRAP analysis, the mean intensity of the bleached area was corrected with background values, as well as the bleaching that occurred during image acquisition. Data were normalized with control fluorescence averaged over 5 initial frames before bleaching and stated as 100% intensity. Average curves were obtained and represented.
Drug treatments
For taxol-induced axon formation experiments, a concentration of 10nM for 48h was used. COS-7 cells were treated with 2-BP at concentrations of 50 mM (for immunocytochemistry) or 100 mM (in live-cell experiments), or PalB at 10 mM for 3h. In neurons, 2-BP and PalB treatments were done at concentrations of 10 mM for 3-4h. Ionomycin and BAPTA treatments were done using concetrations of 1 mM and 3.3 mM, respectively, for 6-7 hr.
Acyl Rac Assay
Acyl Rac Assays were performed as described previously with minor modifications (Forrester et al., 2011) . Briefly, treated/transfected neurons (DIV2) were washed in PBS and collected in lysis buffer (25 mM HEPES, 25 mM NaCl, 1 mM EDTA, pH 7.5) containing protease inhibitor cocktail (Roche). Lysates were centrifuged at 20,000 g for 30 min. Amounts of protein of around 0.3 mg per reaction were used. Methyl methanethiosulfonate (MMTS) and SDS were added to supernants to final concentrations of 0.1% and 2.5%, respectively. The mixture was incubated at 40 C for 10 min with frequent vortexing. Proteins were precipitated by adding three volumes of cold acetone and incubating at À20 C for 20 min. After centrifugation at 5,000 g for 10 min, the pellet was washed with acetone and resuspended in 300 mL of binding buffer (100 mM HEPES, 1.0 mM EDTA, 1% SDS, pH 7.5) and added to 30 mL of prewashed thiopropyl Sepharose. To this mixture was added 40 mL of either freshly prepared 2 M NH 2 OH or 2 M NaCl. Binding reactions were incubated on a rotator at room temperature for 3 hr. Approximately 20 mL of each supernatant was saved as the ''total input.'' Resins were washed at least five times with binding buffer. For immunoblot analysis, elution was performed using 30 mL of SDS-page sample buffer containing DTT and boiled for 10 min.
Inducible cargo trafficking assay
The inducible cargo trafficking assay was performed as describe previously . Briefly, dissociated hippocampal neurons were co-transfected with GFP, FKBP-mRFP-PEX and KIF5B (1-807)-HA-FRB and pSuper control or MAP6 shRNA at DIV1 and imaged at DIV4. To induce specific binding of FRB and FKBP constructs, rapalog was added to a final concentration of 100nM. Within a maximum period of 40 min, different neurons were imaged for 3 min with an interval of 0.5 s.
Image analysis and quantification Data were collected and analyzed from 2-5 independent experiments. No specific strategy for randomization and/or stratification was employed. The studies were blind in data analysis. Grubbs' test was performed to detect significant outliers.
Quantification of immunofluorescence intensity in neurons
Regions of interest of approximately 20 mm long were manually drawn in axons or dendrites using ImageJ. Mean intensity was measured from these regions, background values were subtracted and values were corrected to a-tubulin or b-III tubulin levels. These data were normalized to intensities in controls.
Polarity index
Regions of approximately 20 mm long were drawn from the soma into axons and at least 2 dendrites. Mean intensities in these regions were calculated using ImageJ. Background values were subtracted and values were corrected to a-tubulin or b-III tubulin levels. Polarity index (PI) was calculated using the following formula: PI = (Id-Ia)/(Id+Ia), where Id is the mean dendrite intensity and Ia is the mean axonal intensity. Non-polarized proteins present a PI = 0 (Id = Ia), whereas PI > 0 or PI < 0 indicates polarization toward dendrites or axons, respectively.
Analysis of knockdowns
Hippocampal neurons were transfected with either pSuper control or a shRNA against a specific MAP, together with a fill (BFP). Neurons were fixed 72 hr after transfection and co-stained with an antibody against the knocked down protein together with a-tubulin or b-III tubulin antibody. Mean intensities for the MAPs were quantified in dendrites or axons of control and depleted neurons using ImageJ software. Background values were subtracted and values were corrected to a-tubulin or b-III tubulin levels. Analysis of MAP6 distribution in neurons Plot profiles of MAP6, MAP2, Tau and Na v channels were created from segmented lines traced from the soma along the axon in neurons using ImageJ. Quantification of EB1-comet and NPY-positive vesicles number ImageJ plugin ComDet (https://github.com/ekatrukha/ComDet) was used to quantify the number of EB1 comets or NPY-positive vesicles in soma, dendrites or distal axons. Numbers were normalized to the corresponding area or neurite length. Analysis of neuronal morphology For the analysis of axon morphology, BFP was used as a fill and axon was identified as the longest neurite. Quantifications were performed using ImageJ software and the NeuronJ plugin (Meijering et al., 2004) . Total axonal length was calculated as the sum of the lengths of the axon and its branches. Quantification of MAP6-positive vesicles and microtubules 100 mm 2 areas were randomly selected from control and treated COS-7 cells. Number of MAP6-positive vesicles and microtubules were quantified and averaged.
Quantification of vesicle colocalization
Number of vesicles labeled with only green, only red or labeled with both green and red markers was quantified. The percentage of green and red double-positive vesicles compared to the total number of green and red vesicles was calculated.
Pearson's coefficient quantification Pearson's coefficient was determined using the JACoP plugin (Bolte and Cordeliè res, 2006) for ImageJ. For each cell, three ROIs were selected and Pearson's coefficient was average per cell.
Quantification of moving particles
Run length, time, and velocity of dynamic microtubules (labeled with GFP-MACF43), mitochondria (labeled with mito-ds Red), peroxisome (tracked with PEX3-RFP-FKBP) or KIF5B molecules (labeled with KIF5B(1-807)-GFP) were quantified from kymographs of proximal axons created using the Kymoreslicewide plug-in under Fiji.
To quantify the percentage of NPY-positive vesicles and vesicles containing N-terminal domain of MAP6 both moving and static vesicles from the approximately last 20 mm of axons were considered. Quantification of western blot data Densitometry of western blots was done using the gel analysis method of ImageJ software. Protein levels were normalized to loading controls.
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical details of experiments, including the definitions and exact values of n, and statistical tests performed, can be found in Figures and Figure Legends . n represents number of analyzed cells in all figures except for Figure 3A (n represents number of mitochondria), Figure 3I (n represents number of slices) and Figures 5A , 5B, and 8F (n represents number of experimental replications). Data processing and statistical analysis were done in Excel and GraphPad Prism (GraphPad Software). Significance was defined as: ns-not significant, *p < 0.05 **p < 0.01 and ***p < 0.001. Statistical analysis include: Unpaired t test, Mann-Whitney U test, one-way ANOVA followed by a Tukey's multiple comparison test, Kruskal-Wallis test followed by a Dunn's Multiple Comparison Test, Two-ways ANOVA followed by Bonferroni post-test, Wilcoxon signed-rank test and Fisher's exact test with Bonferroni correction. The assumption of normality was checked using D'Agostino-Pearson omnibus test.
